Year |
Citation |
Score |
2020 |
Papaevangelou E, Smolarek D, Elhage O, Smith RA, Dasgupta P, Galustian C. Abstract A11: Targeting prostate cancer using novel cytotopically modified immunotherapies intratumorally in a syngeneic murine model Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-A11 |
0.347 |
|
2019 |
Sakellariou C, Elhage O, Papaevangelou E, Giustarini G, Esteves AM, Smolarek D, Smith RA, Dasgupta P, Galustian C. Prostate cancer cells enhance IL-15-mediated expansion of NK cells. Bju International. PMID 31392791 DOI: 10.1111/Bju.14893 |
0.305 |
|
2017 |
Galustian C, Rani A, Cahill F, Santaolalla A, Gillett C, Lombardelli C, Rosekilly J, Sakellariou C, George G, Papaevangelou E, Smith R, Smolarek D, Hemelrijck MV, Dasgupta P. Mutation of duffy antigen receptor for chemokines (DARC) as an indicator of prostate cancer severity in Afro-Caribbean men European Urology Supplements. 16. DOI: 10.1016/S1569-9056(17)30419-0 |
0.318 |
|
2016 |
Karegli J, Melchionna T, Farrar CA, Greenlaw R, Smolarek D, Horsfield C, Charif R, McVey JH, Dorling A, Sacks SH, Smith RA. Thrombalexins: Cell-localized inhibition of thrombin and its effects in a model of high-risk renal transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 27376583 DOI: 10.1111/Ajt.13951 |
0.304 |
|
2015 |
Smolarek D, Hattab C, Buczkowska A, Kaczmarek R, Jarz?b A, Cochet S, de Brevern AG, Lukasiewicz J, Jachymek W, Niedziela T, Grodecka M, Wasniowska K, Colin Aronovicz Y, Bertrand O, Czerwinski M. Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity. Plos One. 10: e0116472. PMID 25706384 DOI: 10.1371/Journal.Pone.0116472 |
0.498 |
|
2015 |
Smolarek D, Sakellariou CA, Dasgupta P, Smith RAG, Galustian C. Abstract 268: Cytotopically modified antibodies to checkpoint proteins can actively reconstitute immune checkpoint blockade and inhibit tumor growth in a prostate cancer mouse model Cancer Research. 75: 268-268. DOI: 10.1158/1538-7445.Am2015-268 |
0.407 |
|
2013 |
Habib I, Smolarek D, Hattab C, Grodecka M, Hassanzadeh-Ghassabeh G, Muyldermans S, Sagan S, Gutiérrez C, Laperche S, Le-Van-Kim C, Aronovicz YC, Wasniowska K, Gangnard S, Bertrand O. V(H)H (nanobody) directed against human glycophorin A: a tool for autologous red cell agglutination assays. Analytical Biochemistry. 438: 82-9. PMID 23541519 DOI: 10.1016/J.Ab.2013.03.020 |
0.446 |
|
2013 |
Habib I, Smolarek D, Hattab C, Grodecka M, Gutiérrez C, Laperche S, LE-Van-Kim C, Colin Aronovicz Y, Wasniowska K, Gangnard S, Bertrand O. Test diagnostique d’immunisation contre le VIH aisément applicable en milieu déshérité reposant sur des VHH (dérivés recombinants d’anticorps de camélidés) Transfusion Clinique Et Biologique. 20: 308-309. DOI: 10.1016/J.Tracli.2013.03.058 |
0.354 |
|
2012 |
Smolarek D, Bertrand O, Czerwinski M. Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine? Postè©Py Higieny I Medycyny Doå›Wiadczalnej (Online). 66: 348-58. PMID 22706121 DOI: 10.5604/17322693.1000334 |
0.464 |
|
2010 |
Smolarek D, Bertrand O, Czerwinski M, Colin Y, Etchebest C, de Brevern AG. Multiple interests in structural models of DARC transmembrane protein. Transfusion Clinique Et Biologique : Journal De La Sociã©Tã© Franã§Aise De Transfusion Sanguine. 17: 184-96. PMID 20655787 DOI: 10.1016/J.Tracli.2010.05.003 |
0.431 |
|
2010 |
Smolarek D, Hattab C, Hassanzadeh-Ghassabeh G, Cochet S, Gutiérrez C, de Brevern AG, Udomsangpetch R, Picot J, Grodecka M, Wasniowska K, Muyldermans S, Colin Y, Le Van Kim C, Czerwinski M, Bertrand O. A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines. Cellular and Molecular Life Sciences : Cmls. 67: 3371-87. PMID 20458517 DOI: 10.1007/S00018-010-0387-6 |
0.511 |
|
2010 |
Smolarek D, Habib I, Hattab C, Cochet S, Hassanzadeh-Ghassabeh G, Gutierrez C, Picot J, Grodecka M, Wasniowska K, Udomsangpetch R, Brevern AGd, Muyldermans S, Colin Y, Kim CLV, Czerwinski M, et al. VHHs or nanobodies directed against proteins of the human red cell membrane Transfusion Clinique Et Biologique. 17: 202. DOI: 10.1016/J.Tracli.2010.06.018 |
0.414 |
|
2009 |
Czerwinski M, Krop-Watorek A, Wasniowska K, Smolarek D, Spitalnik SL. Construction of an agglutination tool: recombinant Fab fragments biotinylated in vitro. New Biotechnology. 26: 215-21. PMID 19833240 DOI: 10.1016/J.Nbt.2009.10.002 |
0.362 |
|
Show low-probability matches. |